Philippines

Pharmaceutical industry players have a bright future in the Philippines. According to IQVIA March 2023 MAT, the Philippines is the third-largest pharmaceutical market in ASEAN, with a value of $4.6 billion. The country's pharmaceutical market is extremely alluring in the ASEAN area due to economic and population expansion.

Alkem started its operations in the country through its fully-owned subsidiary, Alkem Laboratories Corporation, in July 2011. We offer a comprehensive range of specialty products targeting different therapeutic segments for the treatment of patients. We started with Anti-infectives and ventured into Gastroenterology with Proton Pump Inhibitors. Recently, we have added Pain Management and Probiotic therapies to our portfolio. We intend to strengthen our presence in these segments through continuous and strategic new launches.

We focus on developing a strong prescription base for our brands. We are driven by a robust team of medical representatives and managers who are actively building our brands in the Philippines.

Contact Us :